Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Rapivab TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: peramivir
Pack: Rapivab 200 mg/20 mL injection, 3 x 20 mL vials
Brand name
(ARTG)
: RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Rapivab is indicated for the treatment of acute influenza infection in adults and children 2 years and older who have been symptomatic for no more than two days.,Clinical trials have not established the efficacy of repeated doses of Rapivab in patients with serious influenza requiring hospitalisation.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous Infusion
- Clear colourless solution free from visible evidence of particulates
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Light
- Shelf lifetime is 5 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 3 vials (each vial contains 20 mL) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient peramivir
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Need more information?
These trusted information partners have more on this topic.